Do you have urinary pain, urgency and frequency?
If you have symptoms of interstitial cystitis/bladder pain syndrome (IC/BPS), you may be eligible to participate in a clinical research study.
If you are a female between the ages of 18 and 85, with urinary frequency, urgency and pelvic discomfort or pain for at least six months, you may be eligible to participate in a clinical research study.
Can I Participate?
You may be eligible to participate in this research study if you are:
Between the ages of 18-85
Experiencing symptoms of IC/BPS (urinary frequency, urgency and pelvic discomfort or pain) for at least six months
Why Should I Participate?
Participating in this study will give you access to quality care at no cost. Your participation is critical to help improve the care we can give future patients as we learn more about IC/BPS, improve treatments and help with better diagnosis.
If you meet the criteria to be included in the study, you will be scheduled to have:
Twice weekly treatment sessions for eight weeks
Phone or mail monitoring every six months, up to five times after treatment completion
Any treatment will be at no cost to you, a stipend will be provided for study participation. Expected study duration is eight weeks of active treatment with up to two years of follow-up.
What You May Receive
Study related treatment at no cost
Study related procedures
No insurance is neededI'm Interested
to fill out the application
Do I need health insurance?
No, health insurance is not needed to participate.
Is there a cost for me to participate?
Any treatment will be at no cost to you.
Will I be compensated for participating?
Yes, a stipend will be provided for study participation.
What is the goal of this study?
The goal of this study is to evaluate the effectiveness of twice weekly bladder directed therapy in comparison to pelvic floor physical therapy.
Can I choose what treatment group I am involved in?
Study participants are randomly assigned to treatment groups, meaning you cannot choose the treatment group you receive.
How long will the study take place?
The expected study duration is eight weeks of active treatment with up to two years of follow-up.